Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

P La Rosée, AC Horne, M Hines… - Blood, The Journal …, 2019 - ashpublications.org
Hemophagocytic lymphohistiocytosis (HLH) is a severe hyperinflammatory syndrome
induced by aberrantly activated macrophages and cytotoxic T cells. The primary (genetic) …

Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO)

MB Jordan, CE Allen, J Greenberg… - Pediatric blood & …, 2019 - Wiley Online Library
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of pathologic immune activation,
often associated with genetic defects of lymphocyte cytotoxicity. Though a distinctive …

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study

BJ Webb, ID Peltan, P Jensen, D Hoda… - The Lancet …, 2020 - thelancet.com
Background A subset of patients with COVID-19 develops a hyperinflammatory syndrome
that has similarities with other hyperinflammatory disorders. However, clinical criteria …

Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis

EM Eloseily, P Weiser, CB Crayne… - Arthritis & …, 2020 - Wiley Online Library
Objective To assess the benefit of the recombinant human interleukin‐1 receptor antagonist
anakinra in treating pediatric patients with secondary hemophagocytic lymphohistiocytosis …

Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy

G Griffin, S Shenoi, GC Hughes - Best Practice & Research Clinical …, 2020 - Elsevier
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening state of immune
hyperactivation that arises in the setting of genetic mutations and infectious, inflammatory, or …

Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy

KM Mahadeo, SJ Khazal, H Abdel-Azim… - Nature Reviews …, 2019 - nature.com
In 2017, an autologous chimeric antigen receptor (CAR) T cell therapy indicated for children
and young adults with relapsed and/or refractory CD19+ acute lymphoblastic leukaemia …

Macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in childhood inflammatory disorders: diagnosis and management

LA Henderson, RQ Cron - Pediatric Drugs, 2020 - Springer
Macrophage activation syndrome (MAS), a form of secondary hemophagocytic
lymphohistiocytosis, is a frequently fatal complication of a variety of pediatric inflammatory …

Consensus-based guidelines for the recognition, diagnosis, and management of hemophagocytic lymphohistiocytosis in critically ill children and adults

MR Hines, T von Bahr Greenwood, G Beutel… - Critical care …, 2022 - journals.lww.com
OBJECTIVE: Hemophagocytic lymphohistiocytosis is a hyperinflammatory syndrome that
often requires critical care support and remains difficult to diagnose. These guidelines are …

COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?

MJ Ombrello, GS Schulert - Translational Research, 2021 - Elsevier
Although interest in “cytokine storms” has surged over the past decade, it was massively
amplified in 2020 when it was suggested that a subset of patients with COVID-19 developed …

Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature

HE Sönmez, S Demir, Y Bilginer, S Özen - Clinical Rheumatology, 2018 - Springer
Our aim was to report our experiences of pediatric macrophage activation syndrome (MAS)
patients treated with anakinra and to review previous studies reporting anakinra treatment in …